Olinvacimab With Pembrolizumab in Patients With mTNBC

NCT04986852 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Subject recruitment issues and follow-up study plans

Conditions

Metastatic Triple-Negative Breast Cancer

Interventions

DRUG: Olinvacimab

Sponsor

PharmAbcine

Collaborators

[object Object]